FDA Inspection 1169390 — LifeShare Blood Center
The FDA completed an inspection of LifeShare Blood Center on Apr 25, 2022 in El Dorado, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 25, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- El Dorado, AR (United States)